A detailed history of Western Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Western Wealth Management, LLC holds 8,472 shares of GILD stock, worth $795,944. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,472
Previous 3,710 128.36%
Holding current value
$795,944
Previous $254,000 179.53%
% of portfolio
0.04%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $317,101 - $399,960
4,762 Added 128.36%
8,472 $710,000
Q2 2024

Jul 19, 2024

SELL
$63.15 - $72.88 $102,934 - $118,794
-1,630 Reduced 30.52%
3,710 $254,000
Q1 2024

May 02, 2024

SELL
$71.58 - $87.29 $234,997 - $286,573
-3,283 Reduced 38.07%
5,340 $391,000
Q4 2023

Jan 31, 2024

BUY
$73.27 - $83.09 $42,203 - $47,859
576 Added 7.16%
8,623 $698,000
Q3 2023

Nov 07, 2023

BUY
$73.94 - $80.67 $396,392 - $432,471
5,361 Added 199.59%
8,047 $603,000
Q2 2023

Aug 30, 2023

BUY
$76.01 - $86.7 $532 - $606
7 Added 0.26%
2,686 $207,000
Q1 2023

Aug 30, 2023

BUY
$77.31 - $88.08 $541 - $616
7 Added 0.26%
2,679 $222,000
Q4 2022

Feb 02, 2023

SELL
$62.32 - $89.47 $390,808 - $561,066
-6,271 Reduced 70.12%
2,672 $229,000
Q3 2022

Nov 04, 2022

SELL
$59.54 - $68.01 $40,070 - $45,770
-673 Reduced 7.0%
8,943 $554,000
Q2 2022

Jul 18, 2022

BUY
$57.72 - $65.01 $59,971 - $67,545
1,039 Added 12.11%
9,616 $596,000
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $157,832 - $197,780
2,725 Added 46.57%
8,577 $510,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $75,195 - $85,348
1,159 Added 24.7%
5,852 $426,000
Q2 2021

Aug 09, 2021

BUY
$63.47 - $69.35 $297,864 - $325,459
4,693 New
4,693 $323,000
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $209,151 - $238,318
-3,692 Closed
0 $0
Q3 2020

Oct 27, 2020

BUY
$62.1 - $78.08 $496 - $624
8 Added 0.22%
3,692 $234,000
Q2 2020

Jul 20, 2020

BUY
$72.34 - $84.0 $38,195 - $44,352
528 Added 16.73%
3,684 $283,000
Q1 2020

Apr 27, 2020

BUY
$62.63 - $80.22 $197,660 - $253,174
3,156 New
3,156 $236,000
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $263,876 - $295,611
-4,220 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$60.54 - $79.0 $255,478 - $333,380
4,220 New
4,220 $267,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Western Wealth Management, LLC Portfolio

Follow Western Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.